WinCap Financial’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$452K	Buy	9,299 +48	+0.5%	+$2.34K	0.36%	66
2025 Q1	$315K	Buy	9,251 +1,981	+27%	+$67.4K	0.3%	71
2024 Q4	$286K	Buy	+7,270	New	+$286K	0.29%	69